Meda Cash Flow Invites Pipeline Deal at 95% Discount

Meda AB, Sweden’s biggest publicly traded drugmaker, is offering one of the best deals in the world for pharmaceutical companies looking to replenish their pipelines by swallowing up rivals.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.